213 related articles for article (PubMed ID: 33831558)
1. Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes.
Kosanke M; Osetek K; Haase A; Wiehlmann L; Davenport C; Schwarzer A; Adams F; Kleppa MJ; Schambach A; Merkert S; Wunderlich S; Menke S; Dorda M; Martin U
Mol Ther; 2021 Aug; 29(8):2535-2553. PubMed ID: 33831558
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Mutational Burden of Human Induced Pluripotent Stem Cells from an Integrative Multi-Omics Approach.
D'Antonio M; Benaglio P; Jakubosky D; Greenwald WW; Matsui H; Donovan MKR; Li H; Smith EN; D'Antonio-Chronowska A; Frazer KA
Cell Rep; 2018 Jul; 24(4):883-894. PubMed ID: 30044985
[TBL] [Abstract][Full Text] [Related]
3. iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations.
Kwon EM; Connelly JP; Hansen NF; Donovan FX; Winkler T; Davis BW; Alkadi H; Chandrasekharappa SC; Dunbar CE; Mullikin JC; Liu P
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1964-1969. PubMed ID: 28167771
[TBL] [Abstract][Full Text] [Related]
4. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells.
Ji J; Ng SH; Sharma V; Neculai D; Hussein S; Sam M; Trinh Q; Church GM; McPherson JD; Nagy A; Batada NN
Stem Cells; 2012 Mar; 30(3):435-40. PubMed ID: 22162363
[TBL] [Abstract][Full Text] [Related]
5. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
[TBL] [Abstract][Full Text] [Related]
6. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
Zhang L; Wang Y; Zhang Y; Wang L; Huang H
Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome mutational burden analysis of three pluripotency induction methods.
Bhutani K; Nazor KL; Williams R; Tran H; Dai H; Džakula Ž; Cho EH; Pang AWC; Rao M; Cao H; Schork NJ; Loring JF
Nat Commun; 2016 Feb; 7():10536. PubMed ID: 26892726
[TBL] [Abstract][Full Text] [Related]
8. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
[TBL] [Abstract][Full Text] [Related]
9. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
10. Analysis of protein-coding mutations in hiPSCs and their possible role during somatic cell reprogramming.
Ruiz S; Gore A; Li Z; Panopoulos AD; Montserrat N; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Schöler HR; Zhang K; Izpisua Belmonte JC
Nat Commun; 2013; 4():1382. PubMed ID: 23340422
[TBL] [Abstract][Full Text] [Related]
11. An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion.
Shutova MV; Surdina AV; Ischenko DS; Naumov VA; Bogomazova AN; Vassina EM; Alekseev DG; Lagarkova MA; Kiselev SL
Cell Cycle; 2016; 15(7):986-97. PubMed ID: 26919644
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
13. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
[TBL] [Abstract][Full Text] [Related]
14. iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome.
Kosanke M; Davenport C; Szepes M; Wiehlmann L; Kohrn T; Dorda M; Gruber J; Menge K; Sievert M; Melchert A; Gruh I; Göhring G; Martin U
Stem Cell Reports; 2021 Oct; 16(10):2488-2502. PubMed ID: 34560000
[TBL] [Abstract][Full Text] [Related]
15. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
16. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
17. Hotspots of De Novo Point Mutations in Induced Pluripotent Stem Cells.
Yoshihara M; Araki R; Kasama Y; Sunayama M; Abe M; Nishida K; Kawaji H; Hayashizaki Y; Murakawa Y
Cell Rep; 2017 Oct; 21(2):308-315. PubMed ID: 29020618
[TBL] [Abstract][Full Text] [Related]
18. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.
Abyzov A; Mariani J; Palejev D; Zhang Y; Haney MS; Tomasini L; Ferrandino AF; Rosenberg Belmaker LA; Szekely A; Wilson M; Kocabas A; Calixto NE; Grigorenko EL; Huttner A; Chawarska K; Weissman S; Urban AE; Gerstein M; Vaccarino FM
Nature; 2012 Dec; 492(7429):438-42. PubMed ID: 23160490
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming to pluripotency can conceal somatic cell chromosomal instability.
Hamada M; Malureanu LA; Wijshake T; Zhou W; van Deursen JM
PLoS Genet; 2012; 8(8):e1002913. PubMed ID: 22952451
[TBL] [Abstract][Full Text] [Related]
20. Insertion/deletion and microsatellite alteration profiles in induced pluripotent stem cells.
Kamimura S; Suga T; Hoki Y; Sunayama M; Imadome K; Fujita M; Nakamura M; Araki R; Abe M
Stem Cell Reports; 2021 Oct; 16(10):2503-2519. PubMed ID: 34559999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
